Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Extended-release oxycodone
(D05312)		[1] Oxycodone[1] Oxycodone (D05312) 💬[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
2Oxycodone
(D05312)		[1] Oxycodone[1] Oxycodone (D05312) 💬[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[5] 6, 13, 70, 226, 298 💬
3Oxycodone Depot ”Sandoz”, depot tablets
(D05312)		[1] Oxycodone[1] Oxycodone (D05312) 💬[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 298 💬
4OXYCODONE HYDROCHLORIDE
(D05312)		[1] Oxycodone[1] Oxycodone (D05312) 💬[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[4] 6, 70, 226, 298 💬
5Oxycodone naloxone prolonged release tablets
(D05312)		[2] Naloxone,
Oxycodone		[2] Oxycodone (D05312),
Naloxone 💬		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226 💬
6Oxycodone Orion
(D05312)		[1] Oxycodone[1] Oxycodone (D05312) 💬[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 70 💬
7Oxycodone/naloxone prolonged release t
(D05312)		[3] Manganese citrate,
Naloxone,
Oxycodone		[2] Oxycodone (D05312),
Naloxone 💬		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226 💬
8Oxycodone/Naloxone Prolonged Release tablets
(D05312)		[2] Naloxone,
Oxycodone		[2] Oxycodone (D05312),
Naloxone 💬		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6 💬
9Oxycodone/naloxone prolonged release tablets 10 mg /5 mg
(D05312)		[3] Manganese citrate,
Naloxone,
Oxycodone		[2] Oxycodone (D05312),
Naloxone 💬		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6 💬
10Oxycodone/naloxone prolonged release tablets 10/5 mg
(D05312)		[3] Manganese citrate,
Naloxone,
Oxycodone		[2] Oxycodone (D05312),
Naloxone 💬		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226 💬
11Oxycodone/naloxone prolonged release tablets 20 mg /10 mg
(D05312)		[3] Manganese citrate,
Naloxone,
Oxycodone		[2] Oxycodone (D05312),
Naloxone 💬		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6 💬
12Oxycodone/naloxone prolonged release tablets 20/10 mg
(D05312)		[3] Manganese citrate,
Naloxone,
Oxycodone		[2] Oxycodone (D05312),
Naloxone 💬		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226 💬
13Oxycodone/naloxone prolonged release tablets 5 mg /2.5 mg
(D05312)		[3] Manganese citrate,
Naloxone,
Oxycodone		[2] Oxycodone (D05312),
Naloxone 💬		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6 💬
14Oxycodone/naloxone prolonged release tablets 5/2.5 mg
(D05312)		[3] Manganese citrate,
Naloxone,
Oxycodone		[2] Oxycodone (D05312),
Naloxone 💬		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226 💬
15PR Oxycodone
(D05312)		[1] Oxycodone[1] Oxycodone (D05312) 💬[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6 💬